Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q1- Text added to 2020 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
adequacy, Aisling, amplified, Anchen, Arthrex, Assent, bad, Biden, Biovitrum, body, campaign, CJEU, clear, copay, destination, disallow, epinephrine, evidence, finite, Forbion, inactive, insulin, LP, mid, Nephew, Novato, ophthalmology, OPTIC, Presidential, reclassified, reimplement, relapsed, reopen, reopening, Royal, rulemaking, segregation, Shield, Smith, Sobi, supervisory, Swedish, tie, unamortized, Unregistered, vacated, vacating, vehicle, venture, voluntarily, week
Valuein 2020 Q1 filing- Value in 2020 Q2 filing
Original filings
Filing view